HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georg Eschenburg Selected Research

LCL161

10/2018Vincristine resistance in relapsed neuroblastoma can be efficiently overcome by Smac mimetic LCL161 treatment.
10/2017Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α.
11/2016Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georg Eschenburg Research Topics

Disease

7Neuroblastoma
10/2018 - 05/2012
5Neoplasms (Cancer)
10/2015 - 01/2010
2Thrombosis (Thrombus)
11/2017 - 02/2016
1Wounds and Injuries (Trauma)
11/2019
1Inflammation (Inflammations)
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Reperfusion Injury
11/2017
1Intestinal Volvulus (Volvulus)
11/2017
1Hemorrhage
11/2017
1Infarction (Infarctions)
11/2017
1Spermatic Cord Torsion (Testicular Torsion)
11/2017
1Carcinoma (Carcinomatosis)
10/2015
1Infections
11/2014
1Gastroschisis
08/2014
1Hypersensitivity (Allergy)
03/2014
1Latex Hypersensitivity (Latex Allergy)
03/2014
1Spinal Dysraphism (Spina Bifida)
03/2014
1Necrotizing Enterocolitis
11/2013

Drug/Important Bio-Agent (IBA)

4DNA (Deoxyribonucleic Acid)IBA
11/2017 - 01/2010
3LCL161IBA
10/2018 - 11/2016
3Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 11/2014
2Inhibitor of Apoptosis ProteinsIBA
10/2017 - 11/2016
2Messenger RNA (mRNA)IBA
10/2015 - 05/2012
2taurolidineIBA
11/2014 - 05/2014
1LipopolysaccharidesIBA
01/2018
1Protein-Arginine DeiminasesIBA
01/2018
1NeocateIBA
01/2018
1Therapeutic UsesIBA
11/2017
1FibrinIBA
11/2017
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2017
1Tissue Plasminogen Activator (Alteplase)FDA Link
11/2017
1Cell-Free Nucleic AcidsIBA
11/2017
1NVP-TAE684IBA
11/2016
1Malondialdehyde (Propanedial)IBA
02/2016
1inhibin BIBA
02/2016
1Glutathione PeroxidaseIBA
02/2016
1Testosterone (Sustanon)FDA Link
02/2016
1Genetic Markers (Genetic Marker)IBA
10/2015
1DNA VaccinesIBA
10/2015
1AntigensIBA
10/2015
1Peptides (Polypeptides)IBA
10/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014
1Antineoplastic Agents (Antineoplastics)IBA
11/2014
1Immunoglobulin E (IgE)IBA
03/2014
1LatexIBA
03/2014
1Interleukin-8 (Interleukin 8)IBA
11/2013
1Interleukin-6 (Interleukin 6)IBA
11/2013
1LBW242IBA
05/2012
1X-Linked Inhibitor of Apoptosis ProteinIBA
05/2012

Therapy/Procedure

6Therapeutics
11/2019 - 01/2010
3Drug Therapy (Chemotherapy)
10/2017 - 05/2012
1Operative Surgical Procedures
11/2019
1Catheters
11/2014
1Fetal Therapies (Fetal Therapy)
08/2014
1Radiotherapy
01/2010